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Abstract 
Background 
Changes in cardiac gene expression due to myocardial injury are usually assessed in whole 
heart tissue. However, as the heart is a heterogeneous system, spatial and temporal 
heterogeneity is expected in gene expression. 
Results 
In an ischemia/reperfusion (I/R) rat model we evaluated gene expression of mitochondrial 
and cytoplasmatic superoxide dismutase (MnSod, Cu-ZnSod) and thioredoxin reductase 
(trxr1) upon short (4 h) and long (72 h) reperfusion times in the right ventricle (RV), and in 
the ischemic/reperfused (IRR) and the remote region (RR) of the left ventricle. Gene 
expression was assessed by Real-time reverse-transcription quantitative PCR (RT-qPCR). In 
order to select most stable reference genes suitable for normalization purposes, in each 
myocardial region we tested nine putative reference genes by geNorm analysis. The genes 
investigated were: Actin beta (actb), Glyceraldehyde-3-P-dehydrogenase (gapdh), Ribosomal 
protein L13A (rpl13a), Tyrosine 3-monooxygenase (ywhaz), Beta-glucuronidase (gusb), 
Hypoxanthine guanine Phosphoribosyltransferase 1 (hprt), TATA binding box protein (tbp), 
Hydroxymethylbilane synthase (hmbs), Polyadenylate-binding protein 1 (papbn1). According 
to our findings, most stable reference genes in the RV and RR were hmbs/hprt and 
hmbs/tbp/hprt respectively. In the IRR, six reference genes were recommended for 
normalization purposes; however, in view of experimental feasibility limitations, target gene 
expression could be normalized against the three most stable reference genes 
(ywhaz/pabp/hmbs) without loss of sensitivity. In all cases MnSod and Cu-ZnSod expression 
decreased upon long reperfusion, the former in all myocardial regions and the latter in IRR 
alone. trxr1 expression did not vary. 
Conclusions 
This study provides a validation of reference genes in the RV and in the anterior and posterior 
wall of the LV of cardiac ischemia/reperfusion model and shows that gene expression should 
be assessed separately in each region. 
Background 
Cardiac muscle is a heterogeneous system and many parameters such as blood flow and 
perfusion [1-3], patterns of ion channel activation [4-6]. As gene expression is concerned, 
spatial heterogeneity between cardiac chambers as well as between left and right ventricle 
have long been recognized [7,8]. However, mounting evidences suggest that also conduction 
velocity, repolarization heterogeneities, and arrhythmia susceptibility in different left 
ventricle (LV) regions can be attributable to regional differences in their protein expression 
pattern and function [9,10]. The spatial, functional and temporal heterogeneity that is 
distinctive becomes especially relevant in the injured heart [11-13]. 
In vivo occlusion of the left anterior descending (LAD) coronary artery followed by 
reperfusion is extensively used as an animal model of ischemic heart disease. Upon coronary 
obstruction, restoration of blood flow to the ischemic myocardium modulates the size of 
myocardial infarct and the chance of cell survival. However, this process, termed reperfusion, 
per se can also induce injury. The exact mechanism of reperfusion injury has not yet been 
clarified, although it probably involves cellular overload of calcium, mitochondrial 
impairment and oxidative stress-induced damage [14]. The role of endogenous antioxidants 
in reperfusion injury has been studied extensively, although results are not always consistent 
(for a review see [15,16]). In fact, activity or gene expression of antioxidant enzymes has 
been reported to either increase or decrease upon ischemia/reperfusion (I/R) [17-23]. This 
may be due to different experimental conditions and/or to variation of cardiac endogenous 
antioxidant expression at different times of reperfusion [20]. 
Although experimental in vivo ischemia most commonly involves mono-vasal occlusion, 
very few investigations have been addressed to comparative analysis on tissues from different 
LV regions [9,11-13], as most reports on small animal models analyzed the total or partial 
left ventricular tissue [24-26] or even both ventricles combined [27]. 
The working hypothesis of the present study is that gene expression analysis performed 
separately in LAD territory and in the remaining cardiac regions is required as a prior 
condition for an accurate study of the effects of ischemia and reperfusion. 
Real-time reverse-transcription quantitative PCR (RT-qPCR) is the method of choice for 
analyzing gene expression [28]. However, selection of appropriate internal reference genes or 
housekeeping genes is necessary for reliable results in RT-qPCR. Reference gene expression 
should remain constant in the tissues of interest [29] and in the established experimental 
conditions. The lack of these requirements may lead to erroneous or inaccurate results [30-
33]. 
Previously, single reference genes have been widely used to normalize expression of the 
target genes. However, numerous reports have stated that classic reference genes may vary 
extensively in different experimental conditions and tissues and are therefore unsuitable for 
normalization purposes in the absence of an accurate validation [32,34,35]. For example, one 
of the most traditionally used genes for normalization has been gapdh although several 
publications show that its expression is variable and not suitable for normalizing mRNA 
levels [36-38]. 
Normalization against multiple internal reference genes has now become a prerequisite for 
correct expression analysis [39] and software programs devoted to evaluation of expression 
stability and selection of the most suitable reference genes under different experimental 
conditions have been developed [40,41]. This requirement is paramount in a complex tissue 
such as the myocardium that is composed by multiple cell types and especially during 
ischemia-reperfusion where also not specific RNA degradation can take place. 
In an in vivo rat model of myocardial I/R we focused on gene expression of three antioxidant 
enzymes ubiquitously expressed—mitochondrial and cytosolic superoxide dismutase (MnSod 
and Cu-ZnSod respectively) and cytosolic thioredoxin reductase (trxr1)—whose role in the 
protection of ischemia/reperfusion injury has been investigated extensively [16,42,43]. Short 
(4 h) and long (72 h) reperfusion times were considered in order to evaluate the role of these 
antioxidant enzymes during two different phases of cardiac wound healing: the 
necrosis/apoptosis and the proliferation phase respectively [44,45]. 
The first endpoint of our study was to evaluate a set of candidate reference genes for their use 
in normalizing RT-qPCR data in three distinct regions of the heart, namely the right ventricle, 
the central LAD ischemic/reperfused area of the left ventricle, and its undamaged posterior 
wall. 
The second endpoint of the study was to verify alterations in MnSod, Cu-ZnSod and trxr1 
gene expression level upon ischemia/reperfusion-induced oxidative stress in the different 
heart areas at the two different times of reperfusion. 
Results and discussion 
Selection of reference genes 
geNorm software was used to test the candidate reference genes in order to rank them on the 
basis of their expression stability value (M). The M value is the average pairwise variation of 
a particular gene with all other reference genes [40]. The lowest M value corresponds to the 
most stable reference gene, while the highest corresponds to the least stable. geNorm analysis 
of expression stability showed differences in gene expression in the three myocardial regions 
(Figure 1). In all cases, stability gene values were always below the 1.5 cut-off set by the 
algorithm, thereby signifying stable expression levels for all genes. In particular, analysis 
showed that in the RV most stable genes were hmbs/hprt (M = 0.38). In the RR of the left 
ventricle the highest stability was achieved by hmbs/tbp (M = 0.42) while IRR had the highest 
M values, and the most stable genes were ywhaz/pabp (M = 0.64). 
Figure 1 Average expression stability values of the candidate reference genes in the 
different myocardial regions. Average expression stability values (M) of nine candidate 
reference genes as calculated by geNorm software. RV, Right Ventricle; RR, Remote Region 
of the left ventricle; IRR, Ischemic/Reperfused Region of the left ventricle 
It is noteworthy that, as previously reported by Brattelid et al., [37] in a rat model of post-
infarction heart failure, the highest stability was observed in genes encoding proteins 
involved in DNA synthesis/transcription, independently of the myocardial area analyzed, thus 
confirming that they are a suitable alternative to the widely used metabolic gene gapdh as 
reference genes 
The optimal number of reference genes recommended as normalization factor in the distinct 
cardiac regions was calculated with pairwise variation and is shown in Figure 2. 
Vandesompele et al. [40] set 0.15 as a cutoff value below which inclusion of additional genes 
is not required. According to this analysis, two genes were sufficient for adequate 
normalization in the RV (hmbs and hprt) and three in the RR (decreasing rank of stability: 
hmbs, tbp, hprt). In the IRR the number of reference genes to be included was higher, as 
expected for the area most affected by biochemical and cellular changes, and the use of six 
reference genes was recommended for normalization purposes (decreasing rank of stability: 
ywhaz, pabp, hmbs, tbp, hprt, actb). However, as highlighted by Vandesompele and 
colleagues, 0.15 is an arbitrary value and the number of genes used for geometric averaging 
is a trade-off between accuracy and practical considerations such as cost limitations and 
limited amount of sample. Therefore, in order to increase experimental feasibility of regional 
gene expression analysis, target genes were normalized not only with the six reference genes 
computed by geNorm, but also with a reduced number of genes obtained by the progressive 
exclusion of the least stable, down to the three best reference genes. 
Figure 2 Pairwise variation of candidate reference genes. Pairwise variation (Vn/n+1) was 
analyzed between the normalization factors NF(n) and NF(n + 1) by geNorm software to 
determine the optimal number of reference genes required for RT-qPCR data normalization 
the Right Ventricle (RV) (n = 20), Left Remote Region (RR) (n = 20) and 
Ischemic/Reperfused Region (IRR) (n = 20). In the RV, V2/3 is 0.135, well below the 0.15 
value, indicating that the two genes hmbs and hprt would be sufficient for normalizing gene 
expression data. In the RR, analysis of pairwise variation shows that three reference genes 
should be included for gene expression studies in order to obtain a value below 0.15 (V3/4 = 
0.137). Reference genes in the RR therefore should be hmbs, tbp, hprt. Finally, in the IRR, 
analysis of pairwise variation shows that six reference genes should be included for gene 
expression studies in order to obtain a value below 0.15 (V6/7 = 0.148). Reference genes in the 
IA should therefore be ywhaz, pabp, hmbs, tbp, hprt, and actb 
Target gene expression analysis 
Expression of MnSod, Cu-ZnSod and trxr1 was evaluated in the three different cardiac 
regions in sham-operated and in the short and long reperfused animals, according to the 
reference genes as indicated by geNorm (Figure 3). As far as the sham group is concerned, 
we found a significant heterogeneity in the expression level within the two LV areas for both 
mitochondrial and cytosolic SOD, with the higher levels expressed in IRR (p < 0.05 for both). 
trxr1 expression did not vary among the three ventricular regions. 
Figure 3 MnSod, Cu-ZnSod and trxr1 expression levels at different reperfusion times. 
MnSod (A), Cu-ZnSod (B) and trxr1 (C) expression levels in short and long reperfusion times 
upon 30 min of ischemia. Sham animals were pooled together as there were no evident 
differences between short and long reperfusion times (sham n = 5; short n = 9; long n = 6). 
Results are expressed as mean ± SE. *p < 0.05; ** p < 0.01; ***p < 0.001 
Regarding MnSod, there was an evident drop in expression level in all three cardiac regions 
upon long reperfusion time only (Figure 3A). In the RV and in the RR MnSod expression 
decreased of 54 and 40% with respect to sham (p < 0.01 and p < 0.05 respectively). In the 
IRR, expression level decreased of 83% with respect to sham (p < 0.001). 
A decrease in MnSod activity upon ischemia and reperfusion has been previously described 
[46,47]. However, our experimental setting disclosed that although a decrease of expression 
occurs in all cardiac regions, it is greater in the IRR and occurs only in the long reperfusion 
time, corresponding to the proliferative phase of wound healing during which fibroblasts and 
endothelial cells proliferate and matrix proteins are produced [44]. On the contrary, Cu-
ZnSod expression did not vary with respect to sham in the RV and RR at all times. However, 
in the IRR, after long reperfusion there was a drop of 83% (p < 0.01 vs sham) (Figure 3B). 
Finally trxr1 expression levels did not vary significantly upon I/R during either short nor long 
reperfusion with respect to sham in all cardiac regions (Figure 3C). 
To explore the influence of the normalization strategy used we compared the expression of 
the two target genes that are modulated by I/R normalized either to the subset of genes 
selected according to geNorm analysis (Figure 3), or to gapdh (Figure 4), one of the most 
frequently used reference gene in the literature. Figure 4 shows that normalization with gapdh 
modified the pattern of expression thereby altering the results observed in Figure 3. 
Figure 4 MnSod, Cu-ZnSod and trxr1 expression levels normalized according to gapdh. 
MnSod (A), Cu-ZnSod (B) and trxr1 (C) expression levels normalized to gapdh in sham 
operated animals and in short and long reperfusion times upon 30 min of ischemia (sham n = 
5; short n = 9; long n = 6) 
We tested whether results obtained by normalization in the IRR against the six reference 
genes retained significance also when normalizing with a progressively reduced number of 
genes. Analysis was performed only on mitochondrial and cytoplasmic SOD that exhibited a 
significant variation of expression. 
Figure 5 shows expression levels of MnSod (panel A) and Cu-ZnSod (panel B) normalized 
with 6, 5, 4 and 3 genes. Results did not change when normalization was performed with a 
reduced number of genes, and when observed, the degree of statistical significance remained 
the same. 
Figure 5 Normalization of MnSod and Cu-ZnSod in the IRR with decreasing number of 
reference genes. Relative expression of MnSod (A) and Cu-ZnSod (B) expression level in the 
IRR with 6, 5, 4 and 3 of the most stable reference genes as indicated by geNorm analysis. 
(sham n = 5; short n = 9; long n = 6) 
These data suggest that in the rat model of in vivo cardiac I/R, expression analysis may be 
accurately performed by selecting the appropriate reference genes for each region and even 
reducing the number of reference genes suggested by geNorm analysis. This becomes 
reasonable considering the hands-on implications (laboratory costs and time) and in 
consideration of the limiting quantity of the sample that occurs when a spatial analysis is 
carried out on small-sized experimental models (rats and mice). 
Conclusions 
In summary, gene expression of both reference and target genes reflects cardiac heterogeneity 
in the ischemic and reperfused heart. 
geNorm analysis has shown that reference gene stability varies among the three myocardial 
regions analyzed: hmbs, hprt and hmbs, tbp, hprt are suitable reference genes in the right 
ventricle and in the Remote region respectively. Although in the ischemic reperfused region 
instability is higher, three reference genes could be sufficient for adequate normalization 
(ywhaz, pabp, hmbs). 
We show that Cu-ZnSod and MnSod, but not trxr1 expression, varies in the different heart 
regions during the proliferative phase of post-ischemic wound healing. 
Previous investigations report differences in gene expression of antioxidant enzymes in post-
infarcted myocardium of rats [13,23,47,48]. However, excluding a few cases [13,48], gene 
expression is most commonly studied in the whole heart in spite of specific spatial 
differences in gene expression of both reference and target genes. Whenever a region-specific 
variability in gene expression occurs, as is the case of Cu-ZnSod reported in our study, 
analysis of the heart as a whole could lead to misleading results by either an over- or under-
estimation bias. 
A more general survey of spatial and temporal expression of antioxidant-coding genes could 
offer useful knowledge of the relation between the different phases of cardiac repair as well 
as constitute possible therapeutic targets. 
Although our study was limited to the assessment of antioxidant gene changes related to 
ischemia-reperfusion, it has a more general value addressing the challenging problems of 
choice and validation of reference genes which apply to other target genes as well, involved 
in cardiac pathological processes. 
Methods 
Ischemia/reperfusion model 
All experiments were performed according to the guidelines of D.Lgs 116 (1992) and 
conformed to the ―Guiding Principles for Research Involving Animals and Human Beings,‖ 
approved by the American Physiological Society. 
Twenty male Wistar rats (8–10 weeks, 250–300 g) were anesthetized by intraperitoneal 
injection of Zoletil 100 ® + xylazine (50 mg/Kg and 3 mg/Kg respectively). The heart was 
exposed through a left lateral thoracotomy and LAD coronary was occluded for 30 min in 15 
animals. Then the knot around the vessel was opened and unrestrained reperfusion allowed. 
At the end of reperfusion, animals were killed. Under deep anesthesia, hearts were arrested in 
diastole by lethal KCl injection. The hearts were then excised and washed for 10 min with 
cold Krebs-Henseleit bicarbonate buffer in Langendorff configuration. 
Reperfused animals were divided into two groups: ―short reperfusion time‖, which were 
reperfused for 4 h after the reopening of the LAD (n = 9) and ―long reperfusion time‖, which 
were reperfused for 72 h after the reopening of the LAD (n = 6). 
A control group of sham-operated animals underwent all surgical procedures except for the 
occlusion of the LAD and were killed in correspondence with the short (n = 3) and the long (n 
= 2) reperfusion times. 
Tissue harvesting 
Hearts were cut below the plane of LAD occlusion and tissue samples were obtained from a) 
the right ventricle wall (RV), b) the core of the LAD territory, i.e., the ischemic reperfused 
region (IRR) in the left ventricular wall, c) the left ventricular free wall remote to LAD 
region (RR). In sham-operated animals tissues were harvested from analogously termed 
corresponding regions; IRR of sham-operated animals corresponded to the area beside the 
LAD in the left ventricle. Samples were snap frozen in liquid nitrogen and stored at −80°C 
until RNA purification was undertaken. 
RNA extraction, quantification and retrotranscription 
Frozen samples were transferred to Tri Reagent (Sigma) and homogenized using TissueLyser 
(Qiagen) according to manufacturer’s instructions. 
Concentration of RNA was determined by measuring optical density at 260 nm. Integrity of 
total RNA was assessed by electrophoresis on 1.2% agarose gels. cDNA was obtained from 1 
μg of total RNA using the iScript (Bio-Rad Laboratories, Hercules, CA, USA) 
retrotranscription kit. 
Reference gene selection and real-time PCR 
Nine candidate reference genes were selected from those most commonly used in literature 
and belonging to different functional classes in order to avoid co-regulation. Primers were 
synthesized by BioFab Research (Roma, Italy). Primer characteristics are described in Table 
1. 
Table 1 Primer sequences of target genes and candidate reference genes for normalization 
Gene 
symbol 
Gene name Accession 
number 
Reference Forward primer (5′-3′) Reverse primer (5′-3′) Amplic 
on 
length 
PCR 
efficiency 
(%) 
Tm (°C) 
actb Actin, beta V01217 [49] AAGTCCCTCACCCTCCCAAAAG AAGCAATGCTGTCACCTTCCC 97 106 82.9°C 
ywhaz tyrosine 3-
monooxygenase/tryptophan 5-
monooxygenase activation 
protein zeta polypetide 
NM_013011.2 [49] GATGAAGCCATTGCTGAACTTG GTCTCCTTGGGTATCCGATGTC 117 94 77.6°C 
rpl13a Ribosomal protein L13A NM_173340 [49] GGATCCCTCCACCCTATGACA CTGGTACTTCCACCCGACCTC 132 104 83.5°C 
gapdh glyceraldehyde-3-phosphate 
dehydrogenase 
NM_01708  CTACCCACGGCAAGTTCAAC CCAGTAGACTCCACGACATAC 138 102 57°C 
gusb Glucuronidase, beta NM_017015  TCACCATCGCCATCAACAACAC GCTTATGTCCTGGACGAAGTAACC 92 94,9 59°C 
hprt Hypoxantine guanine 
phosphoribosyl transferase 
NM_012583  CCCAGCGTCGTGATTAGTGATG TTCAGTCCTGTCCATAATCAGTCC 110 104 59°C 
tbp TATA box binding protein NM_001004198  CACCGTGAATCTTGGCTGTAAAC CGCAGTTGTTCGTGGCTCTC 124 104 58°C 
hmbs Hydroxymethylbilane synthase NM_013168 [50] TCTAGATGGCTCAGATAGCATGCA TGGACCATCTTCTTGCTGAACA 76 95,8 60°C 
Pabpn1 poly(A) binding protein, 
nuclear 1 
116697 http://medgen.uge
nt.be/rtprimerdb 
TATGGTGCGACAGCAGAAGA TATGCAAACCCTTTGGGATG 110 95 60°C 
MnSod Manganese Superoxide 
dismutase 
NM_017051.2  ATCTGAACGTCACCGAGGAG TAGGGCTCAGGTTTGTCCAG 141 96 59°C 
Cu.ZnSod Copper-Zinc Superoxide 
dismutase 
NM_017050 http://medgen.uge
nt.be/rtprimerdb 
CGAGCATGGGTTCCATGTC CTGGACCGCCATGTTTCTTAG 101 96 50°C 
txnr1 Thioredoxin reductase 1 NM_031614.2  GGTGAACACATGGAAGAGCA GGACTTAGCGGTCACCTTGA 111 98 60°C 
Reference and antioxidant-coding gene primer sequences, original references, amplicon sizes, amplification efficiency values and accession 
number for the PCR analyses in the present study 
Real-time PCR was performed using iQ SYBRGreen Supermix (Bio-Rad Laboratories). 
Reactions contained 1X SYBR Green SuperMix (BioRad), 300nM of each primer and 100 ng 
of template in a 25 μl final volume reaction. After an initial denaturation step at 95°C for 3 
min, amplification was performed with 40 cycles of denaturation at 95°C for 15 s and 
annealing at 60°C for 30 s. Amplification was followed by melting curve analysis: a single 
homogeneous peak confirmed specific amplification for each primer pair. 
Relative expression levels of reference genes were determined with the comparative 
threshold cycle (Cq) method. Relative expression levels of target genes were normalized to 
the geometric mean of most stable genes as indicated by geNorm software. All samples were 
run in duplicate and the mean value of each duplicate was used for all further calculations. 
Serial cDNA dilution curves were produced to calculate the amplification efficiency for all 
genes. A graph of threshold cycle vs log10 picograms of diluted sample series was produced. 
The slope of the curve was used to determine the amplification efficiency according to Pfaffl 
[51]: Efficiency = 10(−1/slope). Amplification efficiency values are reported in Table 1. 
Gene expression stability and selection of the most suitable reference genes were evaluated 
with geNorm analysis. To determine the number of optimal genes required for normalization 
the software calculated pairwise variation (Vn/n+1) between Normalization Factor NFn and 
NFn+1 [40]. 
Statistical analysis 
Data are expressed as mean ± SE. Comparisons were made by two-way repeated measures 
ANOVA. When a significant effect of a factor was indicated, the post-hoc Bonferroni test 
was used to isolate the statistical differences. Analyses were performed using SPSS 13 (SPSS 
Inc. Chicago, Il, USA), and a p-value of less than 0.05 was considered statistically 
significant. 
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